Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 42care4

02 6Amphastar Pharmaceuticals

03 1Biological E

04 1Cipla

05 1Eli Lilly

06 1Future Health Pharma Gmbh

07 1Lupin Ltd

08 8Novo Nordisk

09 1ORIFARM GROUP AS

10 1Pharmachim Ab

11 4Tetris Pharma

12 1Viatris

13 6Xeris Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Glucagon

Brand Name : Baqsimi

Dosage Form : Nasal powder

Dosage Strength : mg

Packaging : Endo container 1item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

02

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GLUCAGON

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/VIAL

Packaging :

Approval Date : 2020-12-28

Application Number : 208086

Regulatory Info : RX

Registration Country : USA

blank

03

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : BAQSIMI

Dosage Form : POWDER;NASAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2019-07-24

Application Number : 210134

Regulatory Info : RX

Registration Country : USA

blank

04

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Glucagon

Brand Name : Baqsimi

Dosage Form : Nasal powder

Dosage Strength : mg

Packaging : Endo container 1item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

05

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Glucagon

Brand Name :

Dosage Form : Vial

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

06

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GLUCAGON

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/VIAL

Packaging :

Approval Date : 2025-09-15

Application Number : 218813

Regulatory Info : RX

Registration Country : USA

blank

07

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GLUCAGON

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1998-09-11

Application Number : 20928

Regulatory Info : DISCN

Registration Country : USA

blank

08

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GLUCAGON

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/VIAL

Packaging :

Approval Date : 2025-07-22

Application Number : 214457

Regulatory Info : RX

Registration Country : USA

blank

09

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Glucagon

Brand Name : Glucagen Hypo

Dosage Form : Glucagon 1Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial 1 mg + 1 syringe 1 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Glucagon

Brand Name : Glucagen

Dosage Form : Glucagon 1Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial 1 mg + 1 ampoule solv 1 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

11

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Glucagon

Brand Name : Glucagon Novo Nordisk

Dosage Form : Powder and liquid to the injection fluid, resolution

Dosage Strength : 1 mg

Packaging : Set

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

12

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Glucagon

Brand Name : Glucagon Novo Nordisk

Dosage Form : Powder and liquid to the injection fluid, resolution

Dosage Strength : 1 mg

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Glucagon

Brand Name : Baqsimi

Dosage Form : Nasal powder

Dosage Strength : mg

Packaging : Endo container 1item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GLUCAGON

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/VIAL

Packaging :

Approval Date : 2024-12-12

Application Number : 204468

Regulatory Info : RX

Registration Country : USA

blank

15

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GVOKE PFS

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML)

Packaging :

Approval Date : 2019-09-10

Application Number : 212097

Regulatory Info : DISCN

Registration Country : USA

blank

16

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GVOKE PFS

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 1MG/0.2ML (1MG/0.2ML)

Packaging :

Approval Date : 2019-09-10

Application Number : 212097

Regulatory Info : RX

Registration Country : USA

blank

17

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GVOKE HYPOPEN

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML)

Packaging :

Approval Date : 2019-09-10

Application Number : 212097

Regulatory Info : RX

Registration Country : USA

blank

18

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GVOKE HYPOPEN

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 1MG/0.2ML (1MG/0.2ML)

Packaging :

Approval Date : 2019-09-10

Application Number : 212097

Regulatory Info : RX

Registration Country : USA

blank

19

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GVOKE KIT

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 1MG/0.2ML (1MG/0.2ML)

Packaging :

Approval Date : 2021-08-20

Application Number : 212097

Regulatory Info : RX

Registration Country : USA

blank

20

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

GLUCAGON

Brand Name : GVOKE VIALDX

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 1MG/0.2ML (1MG/0.2ML)

Packaging :

Approval Date : 2025-03-14

Application Number : 212097

Regulatory Info : RX

Registration Country : USA

blank